Similar articles for PMID: 33273031

Year	Number of Results
1989	1
1990	1
1991	1
1992	1
1993	1
1997	2
1999	1
2001	2
2002	3
2004	1
2007	3
2008	4
2009	1
2010	1
2011	3
2012	4
2013	2
2014	9
2015	9
2016	15
2017	11
2018	13
2019	10
2020	10
2021	5
2022	1
2024	0

1

Doonan M. Doonan M. J Nucl Med Technol. 2020 Dec;48(4):304-310. doi: 10.2967/jnmt.120.257436. J Nucl Med Technol. 2020. PMID: 33273031 Free article. Review. No abstract available.

2

An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma.

Giuga M, De Gaetano AM, Guerra A, Infante A, Iezzi R, Spinelli I, Siciliano M, Grieco A, Rapaccini GL, Gasbarrini A, Pompili M, Bonomo L. Giuga M, et al. Eur Rev Med Pharmacol Sci. 2016 Jun;20(12):2515-25. Eur Rev Med Pharmacol Sci. 2016. PMID: 27383300 Free article.

3

Recommendation for terminology: Nodules without arterial phase hyperenhancement and with hepatobiliary phase hypointensity in chronic liver disease.

Motosugi U, Murakami T, Lee JM, Fowler KJ, Heiken JP, Sirlin CB; LI-RADS HBA Working Group. Motosugi U, et al. J Magn Reson Imaging. 2018 Nov;48(5):1169-1171. doi: 10.1002/jmri.26515. J Magn Reson Imaging. 2018. PMID: 30347132

4

Chinese consensus on the clinical application of hepatobiliary magnetic resonance imaging contrast agent: Gadoxetic acid disodium.

Rao SX, Wang J, Wang J, Jiang XQ, Long LL, Li ZP, Li ZL, Shen W, Zhao XM, Hu DY, Zhang HM, Zhang L, Huan Y, Liang CH, Song B, Zeng MS. Rao SX, et al. J Dig Dis. 2019 Feb;20(2):54-61. doi: 10.1111/1751-2980.12707. Epub 2019 Mar 10. J Dig Dis. 2019. PMID: 30693659 No abstract available.

5

Synthesis and Evaluation of Manganese(II)-Based Ethylenediaminetetraacetic Acid-Ethoxybenzyl Conjugate as a Highly Stable Hepatobiliary Magnetic Resonance Imaging Contrast Agent.

Islam MK, Kim S, Kim HK, Kim YH, Lee YM, Choi G, Baek AR, Sung BK, Kim M, Cho AE, Kang H, Lee GH, Choi SH, Lee T, Park JA, Chang Y. Islam MK, et al. Bioconjug Chem. 2018 Nov 21;29(11):3614-3625. doi: 10.1021/acs.bioconjchem.8b00560. Epub 2018 Nov 6. Bioconjug Chem. 2018. PMID: 30383368

6

Approach to the Solitary Liver Lesion: Imaging and When to Biopsy.

Pang EH, Harris AC, Chang SD. Pang EH, et al. Can Assoc Radiol J. 2016 May;67(2):130-48. doi: 10.1016/j.carj.2015.07.005. Epub 2015 Dec 17. Can Assoc Radiol J. 2016. PMID: 26702758 Free article. Review.

7

CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Choi JY, Lee JM, Sirlin CB. Choi JY, et al. Radiology. 2014 Oct;273(1):30-50. doi: 10.1148/radiol.14132362. Radiology. 2014. PMID: 25247563 Free PMC article. Review.

8

Liver Imaging and Hepatobiliary Contrast Media.

Pastor CM, Langer O, Van Beers BE. Pastor CM, et al. Contrast Media Mol Imaging. 2018 Sep 9;2018:2487405. doi: 10.1155/2018/2487405. eCollection 2018. Contrast Media Mol Imaging. 2018. PMID: 30271310 Free PMC article. No abstract available.

9

Gadobenate dimeglumine-enhanced liver magnetic resonance imaging: value of hepatobiliary phase for the detection of focal liver lesions.

Fu GL, Du Y, Zee CS, Yang HF, Li Y, Duan RG, Zeng NL, Xiao DM. Fu GL, et al. J Comput Assist Tomogr. 2012 Jan-Feb;36(1):14-9. doi: 10.1097/RCT.0b013e31823dc139. J Comput Assist Tomogr. 2012. PMID: 22261765

10

Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI.

Denecke T, Steffen IG, Agarwal S, Seehofer D, Kröncke T, Hänninen EL, Kramme IB, Neuhaus P, Saini S, Hamm B, Grieser C. Denecke T, et al. Eur Radiol. 2012 Aug;22(8):1769-75. doi: 10.1007/s00330-012-2422-5. Epub 2012 Mar 22. Eur Radiol. 2012. PMID: 22437921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year